MedPath
NMPA Approval

Carbetocin Injection

国药准字H20249486

December 1, 2024

Drug Information

卡贝缩宫素注射液

注射剂

1ml:100μg

化学药品

December 1, 2024

Company Information

Applicant Company

成都天府国际生物城(双流区凤凰路618号6栋附101号)

Manufacturing Company

成都高新区西部园区西芯大道15号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

卡贝缩宫素注射液 - NMPA 批准文号 | MedPath